Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease

Technology appraisal guidance
Reference number: TA217
Published: 23 March 2011
Last updated: 20 June 2018

Evidence

Supporting evidence

Review decision
Review decision - April 2015
Appendix A: review decision paper (PDF 120 KB)

Published:

28 April 2015